Evidence map›Paper›PMID 42485104›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2026

A Qualitative Study of Patients, Caregivers, and Providers on Barriers to Kidney Retransplantation following Graft Loss.

Anita Marie Slominska, Mathilde Gouin-Bonenfant, Emma Katz, Kathleen Gaudio, Tal Sterling-Eilok, Saly El Wazze, M Khaled Shamseddin, Ann Bugeja, Marie-Chantal Fortin, Julie Ho and 4 more

Abstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Anita Marie SlominskaMEDIC Program, Research Institute of the McGill University Health Centre, Montreal, Quebec.ORCID 0009-0004-1005-3525
Mathilde Gouin-BonenfantMEDIC Program, Research Institute of the McGill University Health Centre, Montreal, Quebec.ORCID 0000-0002-2471-4038
Emma KatzDivision of Nephrology, Department of Medicine, McGill University, Montreal, Quebec.
Kathleen GaudioMEDIC Program, Research Institute of the McGill University Health Centre, Montreal, Quebec.ORCID 0009-0009-0266-017
Tal Sterling-EilokMEDIC Program, Research Institute of the McGill University Health Centre, Montreal, Quebec.
Saly El WazzeMEDIC Program, Research Institute of the McGill University Health Centre, Montreal, Quebec.ORCID 0009-0005-8921-4869
M Khaled ShamseddinDivision of Nephrology, Department of Medicine, Queen's University, Kingston, Ontario.ORCID 0000-0001-7157-4894
Ann BugejaDivision of Nephrology, Department of Medicine, Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario.ORCID 0000-0002-4106-0451
Marie-Chantal FortinCentre de Recherche du Centre Hospitalier de l'Université de Montréal QC, Montreal, Quebec.ORCID 0000-0002-8437-0556
Julie HoDepartment of Internal Medicine, University of Manitoba, Winnipeg, Manitoba.ORCID 0000-0002-8342-9093
Ngan N LamDivisions of Transplant Medicine and Nephrology, Cumming School of Medicine, University of Calgary, Calgary, Alberta.ORCID 0000-0002-0129-7091
Marcelo CantarovichDivision of Nephrology, Department of Medicine, McGill University, Montreal, Quebec.
Elizabeth Anne KinsellaInstitute of Health Sciences Education, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec.ORCID 0000-0002-7306-7957
Shaifali SandalMEDIC Program, Research Institute of the McGill University Health Centre, Montreal, Quebec.ORCID 0000-0003-1941-0598

Funding

CIHR PJT 191952
6 · The paper itself

Abstract

key pointsThis qualitative study explored patient, caregiver, and provider perceived barriers to retransplantation after kidney allograft loss. We identified four medical and nonmedical barriers to retransplantation and four additional barriers to pursuing living donor retransplantation. System-, transplant center-, provider-, and patient-level approaches to address these barriers are highlighted.

backgroundMany kidney transplant recipients experience graft loss, and retransplantation offers a significant survival benefit when compared with waitlisted patients. Yet, trends related to preemptive relisting/retransplantation are suboptimal. Little empirical evidence has explored barriers to kidney retransplantation. We aimed to identify the predominant barriers to retransplantation after graft loss and factors that hinder the pursuit of living kidney donor (LKD) retransplantation.

methodsThis was a qualitative study that used an interpretive descriptive design. Participants included patients with a history of graft loss, caregivers who supported them, and transplant nephrologists, recruited using purposive and snowball sampling techniques. Data collection entailed semistructured interviews that were coded, and an inductive thematic analysis was conducted.

resultsWe synthesized the perspectives of 23 patients, 23 caregivers, and 11 transplant nephrologists representing 11 Canadian transplant programs. Through our analysis, we identified four key barriers to retransplantation: high antibody sensitization resulting in scarcity of compatible donors; prevalence of comorbidities leading to ineligibility or wait list withdrawal; history of nonadherence among the recipients leading to ineligibility or delays in transplant referral and reevaluation; and delayed referrals and poor coordination of retransplant workup. Additional barriers to LKD retransplantation included patient preference for deceased donor transplantation that was unlikely to change after graft loss; perceived smaller pool of eligible LKDs felt to have been exhausted with the first transplant; the psychological burden of unresolved issues related to previous LKD transplant loss; and overall structural barriers to living kidney donation.

conclusionsThis analysis highlights both medical and nonmedical barriers to retransplantation and that the pursuit of retransplantation entails persistent as well as additional and compounding challenges. A list of implications that arise from these findings is presented. Given the well-established benefits of kidney transplantation and that graft loss remains a leading cause of dialysis initiation, these findings have important implications for the nephrology community.

Indexed as

Attitude of Health PersonnelCaregiversKidney TransplantationNephrologistsReoperationAdultAgedFemaleGraft SurvivalHealth Knowledge, Attitudes, PracticeHumansLiving DonorsMaleMiddle AgedQualitative Researchchronic allograft failureESKDkidney transplantationorgan transplantpatient-centered carepatient satisfactionrenal transplantation

Identifiers

PMID42485104
PMCPMC13668228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.